U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427511) titled 'SwissNeuroRehab - HDHI' on Jan. 22.
Brief Summary: High-dose, high-intensity (HDHI) neurorehabilitation has shown promise for improving functional outcomes after acquired brain injury (ABI), yet its feasibility and impact across different stages of care and real-world clinical settings remain insufficiently understood.
The SwissNeuroRehab (SNR) initiative, bringing together Swiss rehabilitation centres to develop and evaluate innovative, technology-supported models of neurorehabilitation, provides the broader framework within which this study is conducted.
Within this framework, a structured HDHI therapy pathway supported by CE-ma...